This company seems to have been delisted
Reason: Acquired by CSL
Last recorded trade on: February 23, 2023
Source: https://www.fiercepharma.com/pharma/csl-agrees-to-11-7-billion-deal-to-acquire-vifor-largest-m-a-deal-year
Reason: Acquired by CSL
Last recorded trade on: February 23, 2023
Source: https://www.fiercepharma.com/pharma/csl-agrees-to-11-7-billion-deal-to-acquire-vifor-largest-m-a-deal-year
Vifor Pharma
VIFN.SW
$314.13
Share price
0.48%
Change (1 day)
8.63%
Change (1 year)
Categories
Earnings for Vifor Pharma (VIFN.SW)
Earnings in 2021: NZ$0.61 Billion
According to Vifor Pharma's latest financial reports the company's current earnings are NZ$1.99 Billion. In 2021 the company made an earning of NZ$0.61 Billion, an increase over its 2020 earnings that were of NZ$0.54 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Vifor Pharma from 2002 to 2021
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2021 | NZ$0.61 B | 13.59% |
| 2020 | NZ$0.54 B | -6.06% |
| 2019 | NZ$0.57 B | 17.13% |
| 2018 | NZ$0.49 B | 81.32% |
| 2017 | NZ$0.27 B | -56.92% |
| 2016 | NZ$0.62 B | -21.21% |
| 2015 | NZ$0.79 B | 17.99% |
| 2014 | NZ$0.67 B | -13.18% |
| 2013 | NZ$0.78 B | 13.39% |
| 2012 | NZ$0.68 B | 7.07% |
| 2011 | NZ$0.64 B | 2.35% |
| 2010 | NZ$0.62 B | 33.45% |
| 2009 | NZ$0.47 B | -2.38% |
| 2008 | NZ$0.48 B | 89.51% |
| 2007 | NZ$0.25 B | 35.56% |
| 2006 | NZ$0.18 B | 32.58% |
| 2005 | NZ$0.14 B | -0.35% |
| 2004 | NZ$0.14 B | -12.49% |
| 2003 | NZ$0.16 B | -37.52% |
| 2002 | NZ$0.25 B |